Kropshofer H, Bohlinger I, Max H, Kalbacher H
Medizinisch-naturwissenschaftliches Forschungszentrum, Universität Tübingen, FRG.
Biochemistry. 1991 Sep 24;30(38):9177-87. doi: 10.1021/bi00102a008.
The acid release of endogenous peptides from immunoaffinity-pure human major histocompatibility complex (MHC) class II proteins HLA-DR1 is accompanied by an 18% decrease in intrinsic tryptophan fluorescence. The effect is totally reversible upon readdition of an autologous endogenous peptide fraction. High-performance size-exclusion chromatographic (HPSEC) binding and release studies with a nonfluorescent HLA-DR1-restricted influenza matrix peptide IM(18-29) prove the fact that Trp residues of the HLA protein change their fluorescence intensities. Since the far-UV circular dichroism spectra of HLA molecules before and after peptide release, DR1[NAT] and DR1[REL], show very small differences, we can rule out the breakdown of secondary structural elements under release conditions, although DR[REL] consists of disassembled alpha- and beta-subunits, as evidenced by HPSEC. Quenching of DR1[NAT] and DR1[REL] using the neutral quencher acrylamide results in a 20% increase in total accessibility of the nine-residue Trp population whereas quenching by iodide yields only a 5% increase. Both results taken together tell us that two Trp residues, preferentially ones located in apolar pockets, become accessible upon the release of peptides. The significantly smaller fluorescence enhancement upon binding IM(18-29) of DR3[REL], exclusively lacking Trp-9(beta 1), and the missing tendency to reassemble under the influence of IM(18-29) compared to DR1[REL] suggest an important role for position 9(beta 1). The region around Trp-43(alpha 1) should be responsible for the binding of IM(18-29) to the alpha-subunits of DR1 and DR3, respectively, as verified by fluorometric HPSEC and SDS-PAGE. Obviously, our findings are in total agreement with the hypothetical MHC class II model, whereafter Trp-9(beta 1) and Trp-43(alpha 1) besides Trp-61(beta 1) are constituents of the binding groove of DR1. Extending the homology to MHC class I products, we postulate the existence of three hydrophobic pockets in the binding site of DR1 with the cited Trp residues being juxtaposed to contacting apolar peptide side chains in HLA-peptide complexes. According to the deduced two-residue-contact model the minimal consensus motif for DR1-restricted peptide antigens consists of two hydrophobic residues lying 14-16 A apart in the bound state of the peptide.
免疫亲和纯的人类主要组织相容性复合体(MHC)II类蛋白HLA - DR1释放内源性肽时,其内在色氨酸荧光会降低18%。重新添加自体内源性肽组分后,这种效应完全可逆。使用非荧光性的HLA - DR1限制性流感基质肽IM(18 - 29)进行的高效尺寸排阻色谱(HPSEC)结合与释放研究证明了HLA蛋白的色氨酸残基会改变其荧光强度这一事实。由于肽释放前后HLA分子DR1[NAT]和DR1[REL]的远紫外圆二色光谱显示出非常小的差异,尽管HPSEC证明DR[REL]由解离的α和β亚基组成,但我们可以排除在释放条件下二级结构元件的破坏。使用中性淬灭剂丙烯酰胺淬灭DR1[NAT]和DR1[REL]会使九个色氨酸残基的总可及性增加20%,而用碘化物淬灭仅使可及性增加5%。综合这两个结果可知,肽释放后两个色氨酸残基(优先位于非极性口袋中的那些)变得可及。与DR1[REL]相比,DR3[REL](仅缺少Trp - 9(β1))结合IM(18 - 29)时荧光增强明显较小,且在IM(18 - 29)影响下重新组装的趋势缺失,这表明9(β1)位具有重要作用。荧光HPSEC和SDS - PAGE验证,Trp - 43(α1)周围区域应分别负责IM(18 - 29)与DR1和DR3的α亚基结合。显然,我们的发现与假设的MHC II类模型完全一致,根据该模型,除了Trp - 61(β1)外,Trp - 9(β1)和Trp - 43(α1)是DR1结合槽的组成部分。将这种同源性扩展到MHC I类产物,我们推测DR1结合位点存在三个疏水口袋,上述色氨酸残基与HLA - 肽复合物中接触的非极性肽侧链并列。根据推导的双残基接触模型,DR1限制性肽抗原的最小共有基序由肽结合状态下相距14 - 16 Å的两个疏水残基组成。